Catalyst Wire Dossier Catalyst Wire Dossier

Gem/Cis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gem/Cis, covering 2023-11-02 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC [Phase 2]

See pricing